NASDAQ
Antisense Therapeutics Limited (ATHJF) has a current ratio of 2.81x as of Monday, May 25, 2026. This represents a 69.29% decrease compared to its 12-month average of 9.15x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.